Biological and Computational Evaluation of Resveratrol Inhibitors against Alzheimer's Disease

The Protein Data Bank

Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196 · see citing works

Comparison of simple potential functions for simulating liquid water

Jorgensen, W. L., Chandrasekhar, J., Madura, J., Impey, R., & Klein, M. (1983) · The Journal of Chemical Physics · doi:10.1063/1.445869 · Cited by 38,335 · see citing works

Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems

Darden, T., York, D., & Pedersen, L. (1993) · The Journal of Chemical Physics · doi:10.1063/1.464397 · Cited by 29,588 · see citing works

Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes

Ryckaert, J., Ciccotti, G., & Berendsen, H. (1977) · Journal of Computational Physics · doi:10.1016/0021-9991(77)90098-5 · Cited by 19,525 · see citing works

Development and testing of a general amber force field

Wang, J.-M., Wolf, R., Caldwell, J., Kollman, P., & Case, D. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20035 · Cited by 18,318 · see citing works

Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand Complexes

Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051256o · Cited by 6,964 · see citing works

Comparison of multiple Amber force fields and development of improved protein backbone parameters

Horn̆ák, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A. E., & Simmerling, C. L. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21123 · Cited by 6,903 · see citing works

Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models

Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., Lee, M., Lee, T., Duan, Y., Wang, W., et al. (2000) · Accounts of Chemical Research · doi:10.1021/ar000033j · Cited by 4,978 · see citing works

PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical p K a Predictions

Olsson, M. H. M., Søndergaard, C. R., Rostkowski, M., & Jensen, J. H. (2011) · Journal of Chemical Theory and Computation · doi:10.1021/ct100578z · Cited by 4,482 · see citing works

Classical Electrostatics in Biology and Chemistry

Honig, B. H., & Nicholls, A. O. (1995) · Science · doi:10.1126/science.7761829 · Cited by 2,883 · see citing works

Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)

Weiser, J., Shenkin, P. S., & Still, W. C. (1999) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(19990130)20:2 · Cited by 1,209 · see citing works

Very fast prediction and rationalization of pKa values for protein–ligand complexes

Bas, D., Rogers, D. M., & Jensen, J. H. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22102 · Cited by 1,096 · see citing works

Langevin stabilization of molecular dynamics

Izaguirre, J. A., Catarello, D. P., Wozniak, J. M., & Skeel, R. D. (2001) · The Journal of Chemical Physics · doi:10.1063/1.1332996 · Cited by 1,086 · see citing works

Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation

Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., et al. (2001) · Nature Neuroscience · doi:10.1038/85059 · Cited by 1,001 · see citing works

Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides

Marambaud, P., Zhao, H., & Davies, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 750 · see citing works

Molecular fields in quantitative structure–permeation relationships: the VolSurf approach

Cruciani, G., Crivori, P., Carrupt, P., & Testa, B. (2000) · Journal of Molecular Structure THEOCHEM · doi:10.1016/s0166-1280(99)00360-7 · Cited by 569 · see citing works

Biomolecular Simulations: Recent Developments in Force Fields, Simulations of Enzyme Catalysis, Protein-Ligand, Protein-Protein, and Protein-Nucleic Acid Noncovalent Interactions

Wang, W., Donini, O., Reyes, C. M., & Kollman, P. A. (2001) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.30.1.211 · Cited by 549 · see citing works

Flavonoids, cognition, and dementia: Actions, mechanisms, and potential therapeutic utility for Alzheimer disease

Williams, R. J., & Spencer, J. P. E. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.010 · Cited by 448 · see citing works

Predicting Blood−Brain Barrier Permeation from Three-Dimensional Molecular Structure

Crivori, P., Cruciani, G., Carrupt, P., & Testa, B. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990968+ · Cited by 431 · see citing works

β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathways

Tamagno, E., Parola, M., Bardini, P., Piccini, A., Borghi, R., Guglielmotto, M., Santoro, G., Davit, A., Danni, O., Smith, M. A., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02895.x · Cited by 324 · see citing works

Strategic approaches to drug design. I. An integrated software framework for molecular modelling

Vinter, J. G., Davis, A., & Saunders, M. R. (1987) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf01680556 · Cited by 322 · see citing works

New and Original pKa Prediction Method Using Grid Molecular Interaction Fields

Milletti, F., Storchi, L., Sforna, G., & Cruciani, G. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700018y · Cited by 311 · see citing works

Neuroprotective effect of natural products against Alzheimer’s disease

Essa, M. M., Vijayan, R. K., Castellano-Gonzalez, G., Memon, M. A., Braidy, N., & Guillemin, G. J. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0799-9 · Cited by 278 · see citing works

Developing β‐secretase inhibitors for treatment of Alzheimer’s disease

Ghosh, A. K., Brindisi, M., & Tang, J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07476.x · Cited by 272 · see citing works

Flavonols and flavones as BACE-1 inhibitors: Structure–activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features

Shimmyo, Y., Kihara, T., Akaike, A., Niidome, T., & Sugimoto, H. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.01.017 · Cited by 234 · see citing works

Protocol for MM/PBSA Molecular Dynamics Simulations of Proteins

Fogolari, F., Brigo, A., & Molinari, H. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74462-2 · Cited by 198 · see citing works

Apo and Inhibitor Complex Structures of BACE (β-secretase)

Patel, S., Vuillard, L. M., Cleasby, A., Murray, C. W., & Yon, J. R. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.08.018 · Cited by 180 · see citing works

Green tea catechins as a BACE1 (β-Secretase) inhibitor

Jeon, S.-Y., Bae, K., Seong, Y.-H., & Song, K. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.018 · Cited by 168 · see citing works

Rapid and Accurate Prediction of Binding Free Energies for Saquinavir-Bound HIV-1 Proteases

Stoica, I., Sadiq, S. K., & Coveney, P. V. (2008) · Journal of the American Chemical Society · doi:10.1021/ja0779250 · Cited by 150 · see citing works

Substrate Binding Mechanism of HIV-1 Protease from Explicit-Solvent Atomistic Simulations

Pietrucci, F., Marinelli, F., Carloni, P., & Laio, A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903045y · Cited by 145 · see citing works

Alzheimer's disease & metals: therapeutic opportunities

Kenche, V. B., & Barnham, K. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01221.x · Cited by 144 · see citing works

Enhanced Phosphatidylinositol 3-kinase (PI3K)/Akt Signaling Has Pleiotropic Targets in Hippocampal Neurons Exposed to Iron-induced Oxidative Stress

Uranga, R. M., Katz, S., & Salvador, G. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.457622 · Cited by 118 · see citing works

The various aggregation states of β-amyloid 1–42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression

Tamagno, E., Bardini, P., Guglielmotto, M., Danni, O., & Tabaton, M. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.021 · Cited by 117 · see citing works

Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation

Shimmyo, Y., Kihara, T., Akaike, A., Niidome, T., & Sugimoto, H. (2008) · Neuroreport · doi:10.1097/wnr.0b013e32830b8ae1 · Cited by 115 · see citing works

Human immunodeficiency virus-1 protease. 1. Initial velocity studies and kinetic characterization of reaction intermediates by oxygen-18 isotope exchange

Hyland, L. J., Tomaszek, T. A., Roberts, G. D., Carr, S. A., Magaard, V. W., Bryan, H., Fakhoury, S. A., Moore, M. L., & Minnich, M. D. (1991) · Biochemistry · doi:10.1021/bi00098a023 · Cited by 114 · see citing works

β-Secretase(BACE1) inhibitors from pomegranate (Punica granatum) husk

Kwak, H.-M., Jeon, S.-Y., Sohng, B.-H., Kim, J.-G., Lee, J.-M., Lee, K., Jeong, H.-H., Hur, J.-M., Kang, Y., & Song, K. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977896 · Cited by 107 · see citing works

Imaging polysaccharides by atomic force microscopy

Kirby, A. R., Gunning, A. P., & Morris, V. J. (1998) · Biopolymers · doi:10.1002/(sici)1097-0282(199603)38:3 · Cited by 107 · see citing works

Chemical Modification of the Multitarget Neuroprotective Compound Fisetin

Chiruta, C., Schubert, D. A., Dargusch, R., & Maher, P. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2012563 · Cited by 102 · see citing works

Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo

Huang, Y., Jin, M.-H., Pi, R., Zhang, J., Ouyang, Y., Chao, X., Chen, M.-H., Liu, P., Yu, J., Ramassamy, C., et al. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2012.12.023 · Cited by 88 · see citing works

Predicting drug resistance of the HIV‐1 protease using molecular interaction energy components

Hou, T., Zhang, W., Wang, J., & Wang, W. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22192 · Cited by 88 · see citing works

Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells

Huang, Y., Jin, M., Pi, R., Zhang, J., Chen, M., Ouyang, Y., Liu, A., Chao, X., Liu, P., Liu, J., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2012.12.051 · Cited by 87 · see citing works

Assigning the Protonation States of the Key Aspartates in β-Secretase Using QM/MM X-ray Structure Refinement

Yu, N., Hayik, S. A., Wang, B., Liao, N., Reynolds, C. H., & Merz, K. M. (2006) · Journal of Chemical Theory and Computation · doi:10.1021/ct0600060 · Cited by 82 · see citing works

β-secretase (BACE1)-inhibiting stilbenoids from Smilax Rhizoma

Jeon, S. Y., Kwon, S.-H., Seong, Y. H., Bae, K., Hur, J.-M., Lee, Y.-Y., Suh, D., & Song, K. S. (2006) · Phytomedicine · doi:10.1016/j.phymed.2006.09.003 · Cited by 81 · see citing works

Tautomer Preference in PDB Complexes and its Impact on Structure-Based Drug Discovery

Milletti, F., & Vulpetti, A. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci900501c · Cited by 80 · see citing works

Virtual Screening for β-Secretase (BACE1) Inhibitors Reveals the Importance of Protonation States at Asp32 and Asp228

Polgár, T., & Keserű, G. M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049133b · Cited by 78 · see citing works

Determination of the Active Site Protonation State of β-Secretase from Molecular Dynamics Simulation and Docking Experiment: Implications for Structure-Based Inhibitor Design

Park, H., & Lee, S. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0304493 · Cited by 77 · see citing works

Modeling the Protonation States of the Catalytic Aspartates in β-Secretase

Rajamani, R., & Reynolds, C. H. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049817j · Cited by 74 · see citing works

Inhibition and structural reliability of prenylated flavones from the stem bark of Morus lhou on β-secretase (BACE-1)

Cho, J. K., Ryu, Y. B., Long, M. J. C., Kim, J. Y., Kim, D., Lee, S., Lee, W. S., & Park, K. H. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.03.060 · Cited by 62 · see citing works

Structure–activity relationships for naturally occurring coumarins as β-secretase inhibitor

Marumoto, S., & Miyazawa, M. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.002 · Cited by 59 · see citing works

Mixed Ligand Cu ²⁺ Complexes of a Model Therapeutic with Alzheimer’s Amyloid-β Peptide and Monoamine Neurotransmitters

Kenche, V. B., Zawisza, I., Masters, C. L., Bal, W., Barnham, K. J., & Drew, S. C. (2013) · Inorganic Chemistry · doi:10.1021/ic302289r · Cited by 59 · see citing works

β-Secretase (BACE-1) inhibitory effect of biflavonoids

Sasaki, H., Miki, K., Kinoshita, K., Koyama, K., Juliawaty, L. D., Achmad, S. A., Hakim, E. H., Kaneda, M., & Takahashi, K. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.021 · Cited by 58 · see citing works

BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens

Hwang, E. M., Ryu, Y. B., Kim, H. Y., Kim, D.-G., Hong, S.-G., Lee, J. H., Curtis-Long, M. J., Jeong, S. H., Park, J.-Y., & Park, K. H. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.05.080 · Cited by 53 · see citing works

<i>In Vitro</i>BACE-1 Inhibitory Activity of Resveratrol Oligomers from the Seed Extract of<i>Paeonia lactiflora</i>

Choi, C., Choi, Y., Cha, M.-R., Kim, Y., Yon, G., Hong, K., Park, W.-K., Kim, Y., & Ryu, S. (2011) · Planta Medica · doi:10.1055/s-0030-1250370 · Cited by 52 · see citing works

Chroman/Catechol Hybrids: Synthesis and Evaluation of Their Activity against Oxidative Stress Induced Cellular Damage

Koufaki, M., Theodorou, E., Galaris, D., Nousis, L., Katsanou, E. S., & Alexis, Μ. N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0506120 · Cited by 49 · see citing works

Engineered Chimeric Enzymes as Tools for Drug Discovery: Generating Reliable Bacterial Screens for the Detection, Discovery, and Assessment of Estrogen Receptor Modulators

Σκρέτας, Γ., Meligova, A. K., Villalonga‐Barber, C., Mitsiou, D. J., Alexis, Μ. N., Micha‐Screttas, M., Steele, B. R., Screttas, C. G., & Wood, D. W. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067754j · Cited by 45 · see citing works

Specificity of resistance to oxidative stress

Dargusch, R., & Schubert, D. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00950.x · Cited by 44 · see citing works

A New Specific BACE-1 Inhibitor from the Stembark Extract ofVitis vinifera

Choi, Y. H., Yoo, M. Y., Choi, C. W., Cha, M., Yon, G. H., Kwon, D. Y., Kim, Y. S., Park, W.-K., & Ryu, S. Y. (2009) · Planta Medica · doi:10.1055/s-0029-1185311 · Cited by 43 · see citing works

Protonation States of the Catalytic Dyad of β-Secretase (BACE1) in the Presence of Chemically Diverse Inhibitors: A Molecular Docking Study

Barman, A., & Prabhakar, R. S. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200611t · Cited by 38 · see citing works

Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: Exploration of P1 phenoxy and benzyloxy residues

Bäck, M., Nyhlén, J., Kvarnström, I., Appelgren, S., Borkakoti, N., Jansson, K., Lindberg, J., Nyström, S., Hallberg, A., Rosenquist, Å., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.09.041 · Cited by 31 · see citing works

New Guaiane Sesquiterpene Lactones fromIxeris dentata

Cha, M., Choi, Y. H., Choi, C. W., Yoo, D., Kim, Y. H., Choi, S., Kim, Y. H., & Ryu, S. Y. (2010) · Planta Medica · doi:10.1055/s-0030-1250369 · Cited by 30 · see citing works

Combining Dyad Protonation and Active Site Plasticity in BACE-1 Structure-Based Drug Design

Kacker, P., Masetti, M., Mangold, M., Bottegoni, G., & Cavalli, A. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200366z · Cited by 27 · see citing works

Linear interaction energy models for β-secretase (BACE) inhibitors: Role of van der Waals, electrostatic, and continuum-solvation terms

Tounge, B. A., Rajamani, R., Baxter, E. W., Reitz, A. B., & Reynolds, C. H. (2005) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2005.10.002 · Cited by 24 · see citing works

Comparison of thermal effects of stilbenoid analogs in lipid bilayers using differential scanning calorimetry and molecular dynamics: correlation of thermal effects and topographical position with antioxidant activity

Koukoulitsa, C., Durdağı, S., Siapi, E., Villalonga‐Barber, C., Alexi, X., Steele, B. R., Micha‐Screttas, M., Alexis, Μ. N., Tsantili‐Kakoulidou, A., & Mavromoustakos, T. (2011) · European Biophysics Journal · doi:10.1007/s00249-011-0705-4 · Cited by 24 · see citing works

Identification of a small molecule beta-secretase inhibitor that binds without catalytic aspartate engagement.

Steele, T., Hills, I. D., Nomland, A., de León, P., Allison, T., McGaughey, G., Colussi, D., Tugusheva, K., Haugabook, S., Espeseth, A. S., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.027 · Cited by 20 · see citing works

Quantum mechanics study of the hydroxyethylamines–BACE-1 active site interaction energies

Gueto-Tettay, C. A., Drosos, J. C., & Vivas‐Reyes, R. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9443-z · Cited by 17 · see citing works

Differential estrogen receptor subtype modulators: Assessment of estrogen receptor subtype-binding selectivity and transcription-regulating properties of new cycloalkyl pyrazoles

Alexi, X., Kasiotis, K. M., Fokialakis, N., Lambrinidis, G., Meligova, A. K., Mikros, E., Haroutounian, S. A., & Alexis, Μ. N. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.09.006 · Cited by 16 · see citing works

New hydroxystilbenoid derivatives endowed with neuroprotective activity and devoid of interference with estrogen and aryl hydrocarbon receptor-mediated transcription

Villalonga‐Barber, C., Meligova, A. K., Alexi, X., Steele, B. R., Kouzinos, C. E., Screttas, C. G., Katsanou, E. S., Micha‐Screttas, M., & Alexis, Μ. N. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.11.018 · Cited by 13 · see citing works

Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates

Bowers, S., Xu, Y., Yuan, S., Probst, G. D., Hom, R. K., Chan, W., Konradi, A. W., Sham, H. L., Zhu, Y. L., Beroza, P., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.01.103 · Cited by 12 · see citing works

On a Possible Neutral Charge State for the Catalytic Dyad in β-Secretase When Bound to Hydroxyethylene Transition State Analogue Inhibitors

Sussman, F., Otero, J. M., Villaverde, M. C., Castro, M., Domínguez, J. L., González-Louro, L., Estévez, R. J., & Estevez, J. C. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101568y · Cited by 12 · see citing works

Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development

Salo‐Ahen, O. M. H., Alanko, I., Bhadane, R. N., Bonvin, A. M. J. J., Honorato, R. V., Hossain, S., Juffer, A. H., Kabedev, A., Lahtela-Kakkonen, M. K., Larsen, A. S., et al. (2020) · Processes · doi:10.3390/pr9010071 · Cited by 693 · see citing works

Recent Developments and Applications of the MMPBSA Method

Wang, C.-H., Greene, D., Xiao, L., Qi, R.-X., & Luo, R. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00087 · Cited by 608 · see citing works

Natural products: A lead for drug discovery and development

Chopra, B., & Dhingra, A. K. (2021) · Phytotherapy Research · doi:10.1002/ptr.7099 · Cited by 491 · see citing works

Ferroptosis Mechanisms Involved in Neurodegenerative Diseases

Reichert, C. O., de Freitas, F. A., Sampaio‐Silva, J., Rokita-Rosa, L., Barros, P. D. L., Levy, D., & Bydlowski, S. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228765 · Cited by 426 · see citing works

Resveratrol and Alzheimer’s Disease: Mechanistic Insights

Ahmed, T., Javed, S., Javed, S., Tariq, A., Šamec, D., Tejada, S., Nabavi, S. F., Braidy, N., & Nabavi, S. M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9839-9 · Cited by 179 · see citing works

Role of natural products for the treatment of Alzheimer’s disease

Noori, T., Dehpour, A. R., Sureda, A., Sobarzo-Sanchez, E., & Shirooie, S. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173974 · Cited by 141 · see citing works

Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?

Mazzanti, G., & Giacomo, S. D. (2016) · Molecules · doi:10.3390/molecules21091243 · Cited by 130 · see citing works

Synthesis of some tetrahydropyrimidine-5-carboxylates, determination of their metal chelating effects and inhibition profiles against acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase

Sujayev, A. R., Garibov, E. N., Taslımı, P., Gülçın, İ., Gojayeva, S., Farzaliyev, V., Alwasel, S. H., & Supuran, C. T. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1156104 · Cited by 124 · see citing works

Resveratrol and Amyloid-Beta: Mechanistic Insights

Jia, Y., Wang, N., & Liu, X. (2017) · Nutrients · doi:10.3390/nu9101122 · Cited by 91 · see citing works

Resveratrol and cognitive decline: a clinician perspective

Cicero, A. F. G., Ruscica, M., & Banach, M. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.85463 · Cited by 77 · see citing works

Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases

Fukutomi, R., Ohishi, T., Koyama, Y., Pervin, M., Nakamura, Y., & Isemura, M. (2021) · Molecules · doi:10.3390/molecules26020415 · Cited by 73 · see citing works

Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes

Piccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., & Pannaccione, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876614 · Cited by 73 · see citing works

Botanicals and phytochemicals active on cognitive decline: The clinical evidence

Cicero, A. F. G., Fogacci, F., & Banach, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.029 · Cited by 70 · see citing works

Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design

Kumar, A., Tiwari, A. K., & Sharma, A. K. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180315141643 · Cited by 59 · see citing works

Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11

Wang, C., Liu, H., Xu, S., Deng, Y. L., Xu, B., Yang, T., & Liu, W. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01343-7 · Cited by 56 · see citing works

Resveratrol-mediated cleavage of amyloid β1–42 peptide: potential relevance to Alzheimer's disease

Al-Edresi, S., Alsalahat, I., Freeman, S., Aojula, H. S., & Penny, J. I. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.04.012 · Cited by 53 · see citing works

Biophenols pharmacology against the amyloidogenic activity in Alzheimer’s disease

Omar, S. H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.051 · Cited by 41 · see citing works

Protective and anti-oxidative effects of curcumin and resveratrol on Aβ-oligomer-induced damage in the SH-SY5Y cell line

Yu, H., Yamashita, T., Hu, X., Bian, Z., Hu, X., Feng, T., Tadokoro, K., Morihara, R., & Abe, K. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120356 · Cited by 37 · see citing works

Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification

Li, Q., Li, Y., Deora, G. S., & Ruan, B. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666190128093840 · Cited by 36 · see citing works

Study of Resveratrol’s Interaction with Planar Lipid Models: Insights into Its Location in Lipid Bilayers

Meleleo, D. (2021) · Membranes · doi:10.3390/membranes11020132 · Cited by 32 · see citing works

Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer’s Disease: Computational Refining and Biochemical Evaluation

Chitranshi, N., Kumar, A., Sheriff, S., Gupta, V. B., Godinez, A., Saks, D., Sarkar, S., Shen, T., Mirzaei, M., Basavarajappa, D. K., et al. (2021) · Cells · doi:10.3390/cells10081946 · Cited by 29 · see citing works

Potential Therapeutic Approaches to Alzheimer’s Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools

Avram, S., Mernea, M., Limban, C., Borcan, F., & Chifiriuc, M. C. (2019) · Current Neuropharmacology · doi:10.2174/1570159x18666191230120053 · Cited by 23 · see citing works

Adequate prediction for inhibitor affinity of Aβ 40 protofibril using the linear interaction energy method

Ngô, S. T., Mai, B. K., Derreumaux, P., & Vu, V. V. (2019) · RSC Advances · doi:10.1039/c9ra01177c · Cited by 21 · see citing works

Effective estimation of the inhibitor affinity of HIV-1 protease via a modified LIE approach

Ngô, S. T., Hong, N. D., Lê, H. Q. A., Hiệp, Đ. M., & Tùng, N. T. (2020) · RSC Advances · doi:10.1039/c9ra09583g · Cited by 10 · see citing works

Structure-based virtual screening for novel potential selective inhibitors of class IIa histone deacetylases for cancer treatment

Elmezayen, A. D., & Yelekçi, K. (2021) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2021.107491 · Cited by 9 · see citing works

Stilbenes Against Alzheimer’s Disease: A Comprehensive Review of Preclinical Studies of Natural and Synthetic Compounds Combined with the Contributions of Developed Nanodrug Delivery Systems

Akkol, E. K., Karatoprak, G. Ş., Dumlupınar, B., Açıkara, Ö. B., Arıcı, R., Yücel, Ç., Aynal, L. C., & Sobarzo‐Sánchez, E. (2025) · Molecules · doi:10.3390/molecules30091982 · Cited by 7 · see citing works

The Potential of Resveratrol as an Anticancer Agent: Updated Overview of Mechanisms, Applications, and Perspectives

Islam, M. R., Ajaj, R., Rauf, A., Shanta, S. S., Al‐Imran, M. I. K., Fakir, M. N. H., Gianoncelli, A., & Ribaudo, G. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.70109 · Cited by 8 · see citing works

Identification of potential human beta-secretase 1 inhibitors by hierarchical virtual screening and molecular dynamics

do Bomfim, M. R., Barbosa, D. B., de Carvalho, P. B., da Silva, A. M., de Oliveira, T. A., Taranto, A. G., & Leite, F. H. A. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2069155 · Cited by 7 · see citing works

Phytochemical Interactions with Calmodulin and Critical Calmodulin Binding Proteins Involved in Amyloidogenesis in Alzheimer’s Disease

O'Day, D. (2023) · Biomolecules · doi:10.3390/biom13040678 · Cited by 7 · see citing works

Phytocompounds as modulators of HSF1 in neurodegenerative disease: Special emphasis on Alzheimer's disease

Nelson, V. K., Begum, M. Y., Dera, A. A., Ali, S. P., & Suryadevara, P. R. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178034 · Cited by 6 · see citing works

Interdisciplinary Approaches to Deal with Alzheimer’s Disease—From Bench to Bedside: What Feasible Options Do Already Exist Today?

Ablinger, I., Dressel, K., Rott, T., Lauer, A. A., Tiemann, M., Batista, J. P., Taddey, T., Grimm, H. S., & Grimm, M. O. W. (2022) · Biomedicines · doi:10.3390/biomedicines10112922 · Cited by 5 · see citing works

Insights Into Resveratrol as an Inhibitor Against Aβ1-42 Peptide Aggregation: A Molecular Dynamics Simulation Study

Borah, P., & Mattaparthi, V. S. K. (2022) · Current Chemical Biology · doi:10.2174/2212796817666221221151713 · Cited by 4 · see citing works

β‐Secretase (BACE1) Inhibitors from Natural Products

Fang, W., Sun, D., Yang, S., & Guo, N. (2017) · doi:10.1002/9783527805921.ch5 · Cited by 4 · see citing works

Curcumin in Alzheimer’s disease diagnosis and treatment

Obulesu, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822448-9.00003-0 · Cited by 1 · see citing works

Nutraceutical approach to age-related diseases—The clinical evidence on cognitive decline

Cicero, A. F. G., & Colletti, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822569-1.00015-9 · Cited by 1 · see citing works

Potential Neuromodulatory Profile of Phytocompounds in Brain Disorders

Trabace, L. (2017) · MDPI eBooks · doi:10.3390/books978-3-03842-317-1

Electrical Properties of Model Lipid Membranes

Naumowicz, M. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-4057-3

Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease

Tang, Y.-W., Shi, C., Yang, H., Cai, P., Liu, Q., Yang, X., Kong, L., & Wang, X. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.040 · Cited by 51 · see citing works

Resveratrol attenuates β-amyloid-induced oxidative stress in astrocytes.

Guo, J., Chen, Q., Zhou, H., Gao, L., Kong, D., & Yu, S. (2010) · Journal of Tropical Medicine

Semisynthesis and biological evaluation of prenylated resveratrol derivatives as multi-targeted agents for Alzheimer’s disease

Puksasook, T., Kimura, S., Tadtong, S., Jiaranaikulwanitch, J., Pratuangdejkul, J., Kitphati, W., Suwanborirux, K., Saito, N., & Nukoolkarn, V. S. (2017) · Journal of Natural Medicines · doi:10.1007/s11418-017-1097-2 · Cited by 41 · see citing works

New Resveratrol Derivatives Exhibit Acetylcholinesterase Inhibitory Properties and Decrease Reactive Oxygen Species Production in the SH-SY5Y Human Neuroblastoma Cell Line

Donozo, M., Cavallaro, V., Baier, C. J., & Murray, A. P. (2023) · International Electronic Conference on Biomedicines (IECBM) · doi:10.3390/ecb2023-14094 · Cited by 2 · see citing works

Neuroprotective effects of resveratrol against β ‐amyloid induced oxidative damage and memory loss in rat hippocampal (H19‐7) cells (647.44)

Rege, S. D., Bottcher, M. R., Geetha, T., Broderick, T. L., & Babu, J. R. (2014) · The FASEB Journal · doi:10.1096/fasebj.28.1_supplement.647.44 · Cited by 1 · see citing works